Beigene Btki News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BeiGene's BTKi is approved in more than 65 markets globally BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, announced today that BRUKINSA (zanubrutinib), a

United statesSouth koreaUnited kingdomGreat britainMehrdad mobasherKevin mannixKyle blankenshipChristine chenRaymond vlesBeigene btkiExchange commissionHealth canadaBeigene ltdEuropean unionPrincess margaret cancer centreChief medical officer